C. Light Technologies
3 known investors
C. Light Technologies develops eye-tracking technology for clinical applications, offering objective metrics to assess patient neurological and vision-related conditions. The company's FDA-approved Retitrack device detects fixational eye movements for use in diagnosing neurodegenerative diseases, brain injuries, and sports vision performance.
AI & Machine LearningHealthtechMedical Devices
Founders & leadership
DC
Dr. Christy Sheehy-BensingerCo-founder and Chief Executive Officer
DJ
Dr. Joe XingCo-founder and Chief Technology Officer
JT
Jacqueline TheisChief Medical Officer
Investors · 3
In the news
- C. Light Named One of Five Selected Projects in the Roche MS Innovation Challengefinance.yahoo.com · 2025
- C. Light Technologies - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Tool Aiming to Diagnose MS via Eye Movement Gets $2.5M Funding Boostmultiplesclerosisnewstoday.com · 2021
- C. Light Technologies rallies $2.5m seedventurecapitaljournal.com · 2021
- C. Light Technologies raises $2.5M seed round to commercialize first ever retinal eye-tracking device for neurodegenerative diseaseprweb.com · 2021